HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia (Q61046312)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18418406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18418406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18418406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

C E Rutten

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18418406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

S A P van Luxemburg-Heijs

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18418406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

E W A Marijt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18418406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

I Jedema

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18418406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

M H M Heemskerk

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18418406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

E F M Posthuma

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18418406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

R Willemze

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18418406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

J H F Falkenburg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18418406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

17 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18418406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18418406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18418406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18418406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

1387-1394

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18418406%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2008.90

5 January 2020

exact match

0 references

cites work

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

Minor histocompatibility antigens in human stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

The molecular basis of allorecognition

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

Recombinant Gamma Interferon Induces HLA-DR Expression on Cultured Human Keratinocytes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

Cytokine dysregulation as a mechanism of graft versus host disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

The biological significance of HLA-DP gene variation in haematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

Minimal GVHD following in-vitro Tcell–depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

CD4(+) bias in T cells cloned from a CML patient with active graft versus leukemia effect

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

Minor histocompatibility antigen-specific T cells with multiple distinct specificities can be isolated by direct cloning of IFNgamma-secreting T cells from patients with relapsed leukemia responding to donor lymphocyte infusion

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

Human-Ir genes: structure and function

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

Alloresponses to HLA-DP detected in the primary MLR: correlation with a single amino acid difference

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021

Cloned primed lymphocyte test cells recognize the fourth, fifth, and sixth hypervariable regions at amino acid positions 65-87 of the DPB1 molecule

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.90

7 January 2021